Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-13-233650
Filing Date
2013-05-23
Accepted
2013-05-23 17:17:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d543115d8k.htm 425 50415
2 EX-2.1 d543115dex21.htm EX-2.1 691804
3 EX-2.3 d543115dex23.htm EX-2.3 74487
  Complete submission text file 0001193125-13-233650.txt   818552
Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
Actavis, Inc. (Filed by) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
Actavis, Inc. (Subject) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-13305 | Film No.: 13869317
SIC: 2834 Pharmaceutical Preparations